Merck: This Cancer-Drug Powerhouse Could Be a Core Dividend
A dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Uncover effective ways to increase points on credit cards and watch your rewards grow. Start optimizing your spending today.
18,895 articlesA dividend-focused investor might overlook Merck at first glance. Yet this cancer‑drug powerhouse blends steady cash ...
Silver has cooled after a sharp rally, but the path ahead remains uncertain. This guide breaks down why silver down f...
A bold investment in a brain health biotech signals conviction in early-stage science. This article breaks down what ...
PayPal faced a liquidity cliff that could have erased the company. This report traces how a crisis, a bold offsite, a...
A thought experiment about a crypto-friendly kevin warsh confirmed as Fed Chair and the potential ripple effects on c...
Boeing stands at greater risk than peers if Elon Musk's Tesla and SpaceX ever join forces, a scenario analysts say co...
The AI boom isn’t a one-stock story. Here are three well-positioned names beyond Nvidia that could fuel the next rall...
Investors are asking where will tesla stock be in three years. This guide lays out base-case forecasts, plausible cat...
A veteran’s retirement plan shows that three tax layers—federal, state, and payroll—can trim a sizable portion of inc...
Bioethicist Ezekiel Emanuel reflects on his father’s long life and the simple, sustainable habits that kept him healt...
Shareholders allege a controlling investor pressured Red Lobster to endure an endless shrimp push, turning a popular ...
A high-profile weekend at Madison Square Garden isn’t just about headlines. It reveals smart money moves and budgetin...